Ophthalmic compositions and methods for treating eyes

Details for Australian Patent Application No. 2005306721 (hide)

Owner Allergan, Inc.

Inventors Vehige, Joseph G.; Chang-Lin, Joan-En; Simmons, Peter A.

Agent Davies Collison Cave

Pub. Number AU-B-2005306721

PCT Pub. Number WO2006/055454

Priority 10/990,811 16.11.04 US

Filing date 14 November 2005

Wipo publication date 26 May 2006

Acceptance publication date 8 March 2012

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/055454 Priority application(s): WO2006/055454

8 March 2012 Application Accepted

  Published as AU-B-2005306721

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005306741-Prodrugs of (2R)-2-propyloctanoic acid for treatment of stroke

2005306715-Off-axis anchor guidance system